drugset / Trial / NCT00671190
Safety and Efficacy of Ramelteon in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the phase-advance in circadian rhythms in healthy adults subjects taking ramelteon, once daily (QD).
Timeline
- Start
- 2005-03
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 1 mg | Oral |
| Subject | Ramelteon | Unknown | 2 mg | Oral |
| Subject | Ramelteon | Unknown | 4 mg | Oral |
| Subject | Ramelteon | Unknown | 8 mg | Oral |